Shanming Wu
China Mobile (China)(CN)
Publications by Year
Research Areas
Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, HIV/AIDS drug development and treatment, Advanced Computational Techniques and Applications
Most-Cited Works
- → Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial(2007)163 cited
- → Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial(2018)120 cited
- → Oxymatrine therapy for chronic hepatitis B: A randomized double-blind and placebo-controlled multi-center trial(2003)84 cited
- → Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters(2003)78 cited
- → State of hepatitis B virus DNA in leucocytes of hepatitis B patients(1985)44 cited
- → Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results(2019)39 cited
- → Comparison of the long-term efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naïve HBeAg-positive patients with chronic hepatitis B(2019)39 cited
- → Long‐term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B(2014)33 cited
- → A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis(2016)32 cited
- → 3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China(2021)31 cited